Evidence map›Paper›PMID 39725436›Full record

ArticleBMJ open2024

Challenges of smoking cessation in users of non-invasive stimulation technologies in Iran: a parallel convergent mixed-methods study.

Mohammad Hasan Sahebihagh, Mina Hosseinzadeh, Mojgan Mirghafourvand, Parvin Sarbakhsh, Hossein Nemati

Abstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammad Hasan SahebihaghTabriz Health Services Management Research Center and Department of Community Health Nursing, Tabriz University of Medical Sciences, Tabriz, Iran.
Mina HosseinzadehDepartment of Community Health Nursing, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID http://orcid.org/0000-0003-1810-0520
Mojgan MirghafourvandSocial Determinants of Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID http://orcid.org/0000-0001-8360-4309
Parvin SarbakhshDepartment of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
Hossein NematiDepartment of Community Health Nursing, Member of Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran nematihossein72@gmail.com.ORCID http://orcid.org/0000-0001-5449-8017

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn recent years, non-invasive stimulation technologies such as repetitive transcranial magnetic stimulation, transcranial direct current stimulation, bioresonance and auriculotherapy have been used for smoking cessation. Individuals may face various challenges throughout the quitting process. This study aimed to explore the challenges of smoking cessation for users of non-invasive stimulation technologies in Iran. DESIGN, SETTING AND

participantsThis parallel-convergent mixed-methods study was conducted using both quantitative and qualitative components. In the quantitative component, a cross-sectional study involved 400 participants, randomly and proportionally sampled from clinics offering non-invasive stimulation technologies for smoking cessation. Data were collected through questionnaires on sociodemographic characteristics and the Challenges to Stopping Smoking scale, with descriptive statistics used for analysis. Participants ranked the challenges based on a predetermined list in the quantitative component. In the qualitative component, 25 users from Tehran, Tabriz and Karaj were selected via purposive and snowball sampling. Data were gathered through in-depth, semistructured individual interviews and analysed using qualitative content analysis with a conventional approach. A merging strategy and convergence model were employed to combine the quantitative and qualitative data.

resultsQuantitative results indicated that 71.5% of participants ranked fear of side effects as a major challenge, making it the most significant issue. Qualitative data also highlighted this, as the primary challenge in smoking cessation. 242 (60.5%) participants declared fear of failure as one of the main challenges. Qualitative data indicated that this often stems from previous unsuccessful quit attempts. The feeling of losing cigarettes was one of the major challenges for 129 (32.2%) participants, reflecting a deep emotional dependency on smoking. While the concern about the cost of using the technology was one of the major challenges for 76 (19.0%) of the participants, qualitative data provided a different perspective, with some participants assessing the high cost of quitting against potential future savings from not buying cigarettes. Fear of relapse was a notable challenge identified in the qualitative data, underscoring the importance of managing triggers and environments during the cessation process.

conclusionsFear of side effects and failure were the most significant challenges in smoking cessation using non-invasive stimulation technologies. Emotional dependency on cigarettes and concerns about the cost also played a role. Fear of relapse was highlighted in qualitative data. To overcome the challenges of smoking cessation with non-invasive stimulation technologies, supportive programmes that provide psychological counselling, financial aid and education are essential to improve success rates.

Indexed as

Smoking CessationAdultCross-Sectional StudiesFemaleHumansIranMaleMiddle AgedQualitative ResearchSurveys and QuestionnairesTranscranial Direct Current StimulationYoung AdultPUBLIC HEALTHSmoking ReductionTobacco Use

Identifiers

PMID39725436
PMCPMC11683994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.